Researchers have revealed that ALT, driven by DAXX mutations, is the driving force behind PanNET neoplastic process, a mechanism separate from the molecular background of pancreatic neuroendocrine carcinoma tumorigenesis, which includes aberrations in the expression of p53 and retinoblastoma protein [110]. This evidence concerns the gene TP53 and pancreatic endocrine carcinoma.